Suzhou Suncadia Biopharmaceuticals Co., Ltd.

This early-stage study tested a new injection called SHR-2017 in 25 patients whose cancer had spread to their bones. The main goal was to understand how the drug moves through the body and to check its initial safety. Researchers also looked to see if it could help reduce severe …